Targeting cancers with tyrosine kinase inhibitors: lessons learned from chronic myeloid leukaemia

被引：3
|
作者：
Mughal, Tariq I.
Goldman, John M.
机构：
[1] Univ Texas SW, Sch Med, Div Hematol & Stem Cell Transplantat, Dallas, TX 75390 USA
[2] Univ London Imperial Coll Sci Technol & Med, London, England
来源：
CLINICAL MEDICINE | 2006年 / 6卷 / 06期
关键词：
D O I：
10.7861/clinmedicine.6-6-526
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：526 / 528
页数：3
相关论文
共 50 条
  • [1] Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?
    Gianantonio Rosti
    Fausto Castagnetti
    Gabriele Gugliotta
    Michele Baccarani
    Nature Reviews Clinical Oncology, 2017, 14 : 141 - 154
  • [2] Tyrosine kinase inhibitors in chronic myeloid leukaemia and emergent cardiovascular disease
    Leong, Darryl
    Aghel, Nazanin
    Hillis, Christopher
    Siegal, Deborah
    Karampatos, Sarah
    Rangarajan, Sumathy
    Pond, Gregory
    Seow, Hsien
    HEART, 2021, 107 (08) : 667 - 673
  • [3] Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?
    Rosti, Gianantonio
    Castagnetti, Fausto
    Gugliotta, Gabriele
    Baccarani, Michele
    NATURE REVIEWS CLINICAL ONCOLOGY, 2017, 14 (03) : 141 - 154
  • [4] TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CHRONIC MYELOID LEUKAEMIA: A SYSTEMATIC REVIEW
    Ferdinand, R.
    Mitchell, S.
    Batson, S.
    Tumur, I.
    HAEMATOLOGICA, 2012, 97 : 533 - 533
  • [5] Risk factors determining adherence to tyrosine kinase inhibitors in chronic myeloid leukaemia
    Garcia, Betel Del Rosario
    Romero, Maria Micaela Vina
    Rosa, Virginia Gonzalez
    Payer, Carolina Alarcon
    Oliva, Leonor Oliva
    Merino Alonso, Francisco Javier Merino
    Casariego, Gloria Julia Nazco
    Nicolas, Fernando Gutierrez
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (05) : 902 - 906
  • [6] Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitors
    Anna Rychter
    Piotr Jerzmanowski
    Adam Hołub
    Zofia Specht-Szwoch
    Violetta Kalinowska
    Urszula Tęgowska
    Ilona Seferyńska
    Agnieszka Kołkowska-Leśniak
    Ewa Lech-Marańda
    Joanna Góra-Tybor
    Medical Oncology, 2017, 34
  • [7] Adherence assessment in Chronic Myeloid Leukaemia patients treated by tyrosine kinase inhibitors
    Daouphars, M.
    Ouvry, M.
    Lenain, P.
    Rouvet, J.
    Varin, R.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (02) : 414 - 415
  • [8] Chronic myeloid leukaemia development in the course of ccRCC treatment with tyrosine kinase inhibitors
    Czarnecka, A. M.
    Oborska, S.
    Rzepecki, P.
    Szczylik, C.
    BJU INTERNATIONAL, 2013, 112 : 12 - 13
  • [9] Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitors
    Rychter, Anna
    Jerzmanowski, Piotr
    Holub, Adam
    Specht-Szwoch, Zofia
    Kalinowska, Violetta
    Tegowska, Urszula
    Seferynska, Ilona
    Kolkowska-Lesniak, Agnieszka
    Lech-Maranda, Ewa
    Gora-Tybor, Joanna
    MEDICAL ONCOLOGY, 2017, 34 (06)
  • [10] Why chronic myeloid leukaemia cannot be cured by tyrosine kinase-inhibitors
    Michele Baccarani
    Robert Peter Gale
    Leukemia, 2021, 35 : 2199 - 2204
12345